Literature DB >> 29967228

Pathways to Cardiorenal Complications in Type 2 Diabetes Mellitus: A Need to Rethink.

Naveed Sattar1, Darren K McGuire2.   

Abstract

Entities:  

Keywords:  atherosclerosis; heart failure; renal disease; sodium balance

Mesh：

Substances：

Year:  2018        PMID： 29967228     DOI： 10.1161/CIRCULATIONAHA.118.035083

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  13 in total

Review 1.  Interpreting Absolute and Relative Risk Reduction in the Context of Recent Cardiovascular Outcome Trials in Patients with Type 2 Diabetes.

Authors:  David D Berg; Ahmed A Kolkailah; Ashish Sarraju; Anne Marie Kerchberger; Mahmoud Eljalby; Darren K McGuire
Journal:  Curr Diab Rep       Date:  2021-11-06       Impact factor: 4.810

2.  Advances in the clinical management of type 2 diabetes: a brief history of the past 15 years and challenges for the future.

Authors:  Naveed Sattar
Journal:  BMC Med       Date:  2019-02-26       Impact factor: 8.775

Review 3.  Treatment of Heart Failure with Sodium-Glucose Cotransporter 2 Inhibitors and Other Anti-diabetic Drugs.

Authors:  Thomas A Zelniker; Eugene Braunwald
Journal:  Card Fail Rev       Date:  2019-02

4.  Higher Body Mass Index in Adolescence Predicts Cardiomyopathy Risk in Midlife.

Authors:  Josefina Robertson; Maria Schaufelberger; Martin Lindgren; Martin Adiels; Linus Schiöler; Kjell Torén; John McMurray; Naveed Sattar; Maria Åberg; Annika Rosengren
Journal:  Circulation       Date:  2019-05-28       Impact factor: 29.690

5.  Contrasting Associations of Body Mass Index and Hemoglobin A1c on the Excess Risk of Acute Myocardial Infarction and Heart Failure in Type 2 Diabetes Mellitus.

Authors:  Jon Edqvist; Araz Rawshani; Martin Adiels; Lena Björck; Marcus Lind; Ann-Marie Svensson; Sofia Gudbjörnsdottir; Naveed Sattar; Annika Rosengren
Journal:  J Am Heart Assoc       Date:  2019-12-10       Impact factor: 5.501

6.  Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation.

Authors:  Susan Martin; Jessica Tyrrell; E Louise Thomas; Matthew J Bown; Andrew R Wood; Robin N Beaumont; Lam C Tsoi; Philip E Stuart; James T Elder; Philip Law; Richard Houlston; Christopher Kabrhel; Nikos Papadimitriou; Marc J Gunter; Caroline J Bull; Joshua A Bell; Emma E Vincent; Naveed Sattar; Malcolm G Dunlop; Ian P M Tomlinson; Sara Lindström; Jimmy D Bell; Timothy M Frayling; Hanieh Yaghootkar
Journal:  Elife       Date:  2022-01-25       Impact factor: 8.713

Review 7.  Canagliflozin for Prevention of Cardiovascular and Renal Outcomes in type2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Lei Tian; Yuzi Cai; Huijuan Zheng; Sinan Ai; Mengqi Zhou; Qian Luo; Jingyi Tang; Weijing Liu; Yaoxian Wang
Journal:  Front Pharmacol       Date:  2021-07-19       Impact factor: 5.810

8.  Diabetes status-related differences in risk factors and mediators of heart failure in the general population: results from the MORGAM/BiomarCaRE consortium.

Authors:  Matti A Vuori; Jaakko Reinikainen; Stefan Söderberg; Ellinor Bergdahl; Pekka Jousilahti; Hugh Tunstall-Pedoe; Tanja Zeller; Dirk Westermann; Susana Sans; Allan Linneberg; Licia Iacoviello; Simona Costanzo; Veikko Salomaa; Stefan Blankenberg; Kari Kuulasmaa; Teemu J Niiranen
Journal:  Cardiovasc Diabetol       Date:  2021-09-28       Impact factor: 9.951

9.  Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants.

Authors:  Ziyi Zhou; John Macpherson; Stuart R Gray; Jason M R Gill; Paul Welsh; Carlos Celis-Morales; Naveed Sattar; Jill P Pell; Frederick K Ho
Journal:  Diabetologia       Date:  2021-06-10       Impact factor: 10.122

Review 10.  The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road?

Authors:  Jiang Liu; Jiang Tian; Komal Sodhi; Joseph I Shapiro
Journal:  J Membr Biol       Date:  2021-07-23       Impact factor: 1.843
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.